Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:21 PM
Ignite Modification Date:
2025-12-24 @ 12:21 PM
NCT ID:
NCT04813861
Eligibility Criteria:
Inclusion Criteria:
* a HCC treated by TACE followed by RFA, MWA and/or CK
* from 01/2010 to 12/2020
* treated by Nancy Regional University Hospital (TACE, RFA, MWA) and Institut de Cancérologie de Lorraine (CK)
Exclusion Criteria:
* Combined treatment over one year following the last TACE
* No baseline, in between or after combined treatment imaging
* Lesion appeared after TACE treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04813861
Study Brief:
Protocol Section:
NCT04813861